人参
根(腹足类)
2019年冠状病毒病(COVID-19)
医学
传统医学
中医药
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
疾病
免疫系统
2019-20冠状病毒爆发
药理学
内科学
爆发
免疫学
替代医学
病毒学
传染病(医学专业)
生物
病理
植物
作者
Xiangda Zhou,Keying Zhang,Lanbo Liu,Qianru Zhao,Ming Huang,Rui Shao,Yanyan Wang,Bin Qu,Yu Wang
标识
DOI:10.1097/hm9.0000000000000033
摘要
Abstract Two years after the coronavirus disease 2019 (COVID-19) outbreak, an increasing number of patients continue to suffer from long COVID (LC), persistent symptoms, and/or delayed or long-term complications beyond the initial 4 weeks from the onset of symptoms. Constant fatigue is one of the most common LC symptoms, leading to severely reduced quality of life among patients. Ginseng Radix et Rhizoma —known as the King of Herbs in traditional Chinese medicine—has shown clinical anti-fatigue effects. In this review, we summarize the underlying anti-fatigue mechanisms of Ginseng Radix et Rhizoma extracts and their bioactive compounds, with a special focus on anti-viral, immune remodeling, endocrine system regulation, and metabolism, suggesting that Ginseng Radix et Rhizoma is a potentially promising treatment for LC, especially in regard to targeting fatigue.
科研通智能强力驱动
Strongly Powered by AbleSci AI